Pair Name | All-trans retinoic acid, Anti-PD-L1 antibody | ||
Phytochemical Name | All-trans retinoic acid (PubChem CID: 444795 ) | ||
Anticancer drug Name | Anti-PD-L1 antibody (PubChem CID: / ) | ||
Structure of Phytochemical |
Download
2D
MOL
3D
MOL
|
||
Structure of Anticancer Drug |
Download
2D
MOL
3D
MOL
|
Pair Name | All-trans retinoic acid, Anti-PD-L1 antibody | |||
Disease Info | [ICD-11: 2C77] | Cervical cancer | Investigative | |
Gene Regulation | Down-regulation | Expression | ARG1 | hsa383 |
Down-regulation | Expression | CD274 | hsa29126 | |
Down-regulation | Expression | CYBB | hsa1536 | |
Up-regulation | Expression | IFNG | hsa3458 | |
Down-regulation | Expression | NOS2 | hsa4843 | |
Up-regulation | Expression | TNF | hsa7124 | |
In Vitro Model | HeLa | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0030 |
C-33 A | Human papillomavirus-independent cervical squamous cell carcinoma | Homo sapiens (Human) | CVCL_1094 | |
U14 | Cervical carcinoma | Mus musculus (Mouse) | CVCL_9U56 | |
In Vivo Model | Mouse cervical cancer U14 cells were prepared as mentioned above and a total of 1×10⁶ U14 cells were subcutaneously injected into the abdominal cavity of the mice for a week. | |||
Result | Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer. |
No. | Title | Href |
---|---|---|
1 | Inhibition of myeloid-derived suppressive cell function with all-trans retinoic acid enhanced anti-PD-L1 efficacy in cervical cancer. Sci Rep. 2022 Jun 10;12(1):9619. doi: 10.1038/s41598-022-13855-1. | Click |